Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC
Clinical trial NCT00236899 · COMPLETED
Trial details
- NCT number
- NCT00236899
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2010-08-01
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.